Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease (original) (raw)
Immune Responses against Major Outer Membrane Antigens of Neisseria meningitidis in Vaccinees and Controls Who Contracted Meningococcal Disease during the Norwegian Serogroup B Protection Trial
Einar Rosenqvist
Infection and Immunity, 1998
View PDFchevron_right
Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac
Stephen Taylor, Andrew Gorringe
Infection and Immunity, 2007
View PDFchevron_right
Immunogenicity, Reactogenicity, and Safety of a P1.7b,4 Strain-Specific Serogroup B Meningococcal Vaccine Given to Preteens
Joanna Stewart, Ingeborg Aaberge
Clinical and Vaccine Immunology, 2007
View PDFchevron_right
Meningococcal vaccines
Seyed Davar Siadat, Mehrangiz Zangeneh
View PDFchevron_right
Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine
David Barroso
FEMS Immunology & Medical Microbiology, 2000
View PDFchevron_right
Immunization against serogroup B meningococci
Gunnar Bjune
APMIS, 1991
View PDFchevron_right
Preclinical Studies and Clinical Trials in Determination of Safety and Efficacy of Meningococcal Vaccines: Present Scenario
sutapa biswas majee
Asian Journal of Pharmaceutical and Clinical Research, 2021
View PDFchevron_right
Immunogenicity and Safety of a Combination of Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines
Ingeborg Aaberge
Clinical and Vaccine Immunology, 2007
View PDFchevron_right
Neisseria meningitidis B vaccines
D. Amicizia
Expert Review of Vaccines, 2011
View PDFchevron_right
Human Antibody Responses to Meningococcal Outer Membrane Antigens After Three Doses of the Norwegian Group B Meningococcal Vaccine
Gunnar Bjune
Infection and …, 1995
View PDFchevron_right
Breadth and Duration of Meningococcal Serum Bactericidal Activity in Health Care Workers and Microbiologists Immunized with the MenB-FHbp Vaccine
eduardo lujan
Clinical and Vaccine Immunology
View PDFchevron_right
Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies
M. Safadi
Expert Review of Vaccines, 2011
View PDFchevron_right
Interlaboratory Standardization of the Measurement of Serum Bactericidal Activity by Using Human Complement against Meningococcal Serogroup B, Strain 44/76-SL, before and after Vaccination with the Norwegian MenBvac Outer Membrane Vesicle Vaccine
Ingeborg Aaberge
Clinical and Vaccine Immunology, 2005
View PDFchevron_right
Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile
wilton silva
Vaccine, 1995
View PDFchevron_right
Advances in the Development of Vaccines against Neisseria meningitidis
George Carlone
New England Journal of Medicine, 2010
View PDFchevron_right
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study
Mark Alderson
The Lancet. Infectious diseases, 2018
View PDFchevron_right
Phase I Safety and Immunogenicity Study of a Candidate Meningococcal Disease Vaccine Based on Neisseria lactamica Outer Membrane Vesicles
Charlotte Brooke
Clinical and Vaccine Immunology, 2009
View PDFchevron_right
Combined Administration of Meningococcal Serogroup B Outer Membrane Vesicle Vaccine and Conjugated Serogroup C Vaccine Indicated for Prevention of Meningococcal Disease Is Safe and Immunogenic
Hanne Nøkleby
Clinical and Vaccine Immunology, 2005
View PDFchevron_right
Vaccines for the prevention of meningococcal disease in children
M. Soriano-gabarró
Seminars in Pediatric Infectious Diseases, 2002
View PDFchevron_right
Immunogenicity of 2 Serogroup B Outer-Membrane Protein Meningococcal Vaccines
Jan Poolman
JAMA, 1999
View PDFchevron_right
An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine
Jehan Alrahimi
Novel Research in Microbiology Journal, 2021
View PDFchevron_right
Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines …
Einar Rosenqvist
The Journal of infectious diseases
View PDFchevron_right
serum bactericidal activity and protection against group B meningococci
salvatore papasergi
View PDFchevron_right